196 related articles for article (PubMed ID: 35788691)
1. miRNA Signature in Early-stage Mycosis Fungoides.
Sørensen ST; Litman T; Gluud M; Celis P; Torres-Rusillo S; Willerslev-Olsen A; Ødum N; Iversen L; Lindahl LM
Acta Derm Venereol; 2022 Oct; 102():adv00785. PubMed ID: 35788691
[TBL] [Abstract][Full Text] [Related]
2. Primary cutaneous anaplastic large cell lymphoma shows a distinct miRNA expression profile and reveals differences from tumor-stage mycosis fungoides.
Benner MF; Ballabio E; van Kester MS; Saunders NJ; Vermeer MH; Willemze R; Lawrie CH; Tensen CP
Exp Dermatol; 2012 Aug; 21(8):632-4. PubMed ID: 22776000
[TBL] [Abstract][Full Text] [Related]
3. miRNA expression profiling of mycosis fungoides.
van Kester MS; Ballabio E; Benner MF; Chen XH; Saunders NJ; van der Fits L; van Doorn R; Vermeer MH; Willemze R; Tensen CP; Lawrie CH
Mol Oncol; 2011 Jun; 5(3):273-80. PubMed ID: 21406335
[TBL] [Abstract][Full Text] [Related]
4. Aberrant microRNA expression in tumor mycosis fungoides.
Papadavid E; Braoudaki M; Bourdakou M; Lykoudi A; Nikolaou V; Tounta G; Ekonomidi A; Athanasiadis E; Spyrou G; Antoniou C; Kitsiou-Tzeli S; Rigopoulos D; Kolialexi A
Tumour Biol; 2016 Nov; 37(11):14667-14675. PubMed ID: 27623940
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-106b Regulates Expression of the Tumour Suppressors p21 and TXNIP and Promotes Tumour Cell Proliferation in Mycosis Fungoides.
Lindahl LM; Gluud M; Emmanuel T; Thomsen EA; Hu T; Rittig AH; Celis P; Stolearenco V; Krejsgaard T; Johansen C; Willerslev-Olsen A; Buus TB; Woetmann A; Aagaard L; Geisler C; Litman T; Mikkelsen JG; Odum N; Iversen L
Acta Derm Venereol; 2020 Sep; 100(16):adv00270. PubMed ID: 32556351
[TBL] [Abstract][Full Text] [Related]
6. Prognostic miRNA classifier in early-stage mycosis fungoides: development and validation in a Danish nationwide study.
Lindahl LM; Besenbacher S; Rittig AH; Celis P; Willerslev-Olsen A; Gjerdrum LMR; Krejsgaard T; Johansen C; Litman T; Woetmann A; Odum N; Iversen L
Blood; 2018 Feb; 131(7):759-770. PubMed ID: 29208599
[TBL] [Abstract][Full Text] [Related]
7. The MicroRNA Expression Profile Differs Between Erythrodermic Mycosis Fungoides and Sézary Syndrome.
Rittig AH; Lindahl LM; Johansen C; Celis P; Ødum N; Iversen L; Litman T
Acta Derm Venereol; 2019 Nov; 99(12):1148-1153. PubMed ID: 31453630
[TBL] [Abstract][Full Text] [Related]
8. Mycosis fungoides: classic disease and variant presentations.
Howard MS; Smoller BR
Semin Cutan Med Surg; 2000 Jun; 19(2):91-9. PubMed ID: 10892710
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and advanced cutaneous T-cell lymphoma.
Ralfkiaer U; Lindahl LM; Litman T; Gjerdrum LM; Ahler CB; Gniadecki R; Marstrand T; Fredholm S; Iversen L; Wasik MA; Bonefeld CM; Geisler C; Krejsgaard T; Glue C; Røpke MA; Woetmann A; Skov L; Grønbæk K; Odum N
Anticancer Res; 2014 Dec; 34(12):7207-17. PubMed ID: 25503151
[TBL] [Abstract][Full Text] [Related]
10. Mycosis fungoides progression could be regulated by microRNAs.
Manso R; Martínez-Magunacelaya N; Eraña-Tomás I; Monsalvez V; Rodríguez-Peralto JL; Ortiz-Romero PL; Santonja C; Cristóbal I; Piris MA; Rodríguez-Pinilla SM
PLoS One; 2018; 13(6):e0198477. PubMed ID: 29894486
[TBL] [Abstract][Full Text] [Related]
11. Expression of T-cell receptor antigens in mycosis fungoides and inflammatory skin lesions.
Michie SA; Abel EA; Hoppe RT; Warnke RA; Wood GS
J Invest Dermatol; 1989 Jul; 93(1):116-20. PubMed ID: 2473133
[TBL] [Abstract][Full Text] [Related]
12. Mycosis fungoides with focal CD 30 transformation in an adolescent.
Romero M; Haney M; Desantis E; Zlotoff B
Pediatr Dermatol; 2008; 25(5):565-8. PubMed ID: 18950403
[TBL] [Abstract][Full Text] [Related]
13. Eosinophils in mycosis fungoides: an uncommon finding in the patch and plaque stages.
Dalton SR; Chandler WM; Abuzeid M; Hossler EW; Ferringer T; Elston DM; LeBoit PE
Am J Dermatopathol; 2012 Aug; 34(6):586-91. PubMed ID: 22814317
[TBL] [Abstract][Full Text] [Related]
14. Lymphomatoid papulosis associated with mycosis fungoides: clinicopathological and molecular studies of 12 cases.
Gallardo F; Costa C; Bellosillo B; Solé F; Estrach T; Servitje O; García-Muret MP; Barranco C; Serrano S; Pujol RM
Acta Derm Venereol; 2004; 84(6):463-8. PubMed ID: 15844638
[TBL] [Abstract][Full Text] [Related]
15. The patch stage of mycosis fungoides. Criteria for histologic diagnosis.
Sanchez JL; Ackerman AB
Am J Dermatopathol; 1979; 1(1):5-26. PubMed ID: 549480
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of mycosis fungoides by 308 nm excimer laser: a clinical and histological study in 10 patients].
Passeron T; Angeli K; Cardot-Leccia N; Perrin C; Lacour JP; Ortonne JP
Ann Dermatol Venereol; 2007 Mar; 134(3 Pt 1):225-31. PubMed ID: 17389845
[TBL] [Abstract][Full Text] [Related]
17. Stage-dependent Increase in Expression of miR-155 and Ki-67 and Number of Tumour-associated Inflammatory Cells in Folliculotropic Mycosis Fungoides.
Atzmony L; Moyal L; Feinmesser M; Gorovitz B; Hirshberg A; Amitay-Laish I; Prag-Naveh H; Barzilai A; Hodak E
Acta Derm Venereol; 2020 Aug; 100(15):adv00230. PubMed ID: 32556361
[TBL] [Abstract][Full Text] [Related]
18. [Mycosis fungoides in childhood and adolescence with clonal T-cell receptor gamma gene rearrangement. Two cases].
Krokowski M; Winzer M; Lange K; Thorns C; Gafumbegete E; Feller AC; Merz H
Hautarzt; 2003 Jun; 54(6):536-40. PubMed ID: 12759739
[TBL] [Abstract][Full Text] [Related]
19. Thymus and activation-regulated chemokine (TARC/CCL17) in mycosis fungoides: serum TARC levels reflect the disease activity of mycosis fungoides.
Kakinuma T; Sugaya M; Nakamura K; Kaneko F; Wakugawa M; Matsushima K; Tamaki K
J Am Acad Dermatol; 2003 Jan; 48(1):23-30. PubMed ID: 12522366
[TBL] [Abstract][Full Text] [Related]
20. [Mycosis fungoides or inflammatory dermatitis: differential diagnosis between early lymphoma and inflammation in skin biopsies].
Oschlies I; Klapper W
Pathologe; 2013 May; 34(3):215-24. PubMed ID: 23549914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]